Undisclosed GPR68 NAM
/ Cumulus Oncology, leadXpro
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 16, 2025
A novel GPR68 (OGR1) negative allosteric modulator shows efficacy in the Dextran Sulphate Sodium (DSS)-induced mouse model of Ulcerative Colitis and modulates the immunosuppressive phenotype of human colorectal fibroblasts
(ECCO-IBD 2026)
- No abstract available
Preclinical • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
1 to 1
Of
1
Go to page
1